证券记录 · 已归档季度
VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
22被追踪持有人
-3Δ持有人
488.65M持有股份
$4.84B报告持仓市值
+0新建仓位
−4清仓
动量输入（同类管理人）：
持有人广度 -12.0% ·
股份流向 +1.9% ·
净新建仓位 -18.2%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 10.99M | $194.70M | n/a | −2 |
| Q2 2026 | 148 | -1 | 754.00M | $11.97B | +6 | −8 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | n/a | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | n/a |
| Q2 2024 | 18 | n/a | 121.66M | $1.29B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 140.27M | -3.3% | $1.39B | 0.0% | ▼ Trim | 2 | SEC ↗ ×7 |
| 2 | T. Rowe Price ✦ | 84.06M | +6.7% | $832.24M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 3 | BlackRock ✦ (被动) | 81.96M | -1.1% | $811.40M | 0.0% | ▼ Trim | 2 | SEC ↗ ×21 |
| 4 | State Street Global Advisors ✦ (被动) | 55.71M | +0.8% | $551.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 29.92M | -4.2% | $295.62M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 16.58M | n/a | $164.10M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 7 | JPMorgan Chase ✦ | 13.31M | n/a | $131.78M | 0.0% | n/c | 1 | SEC ↗ ×30 |
| 8 | Fidelity (FMR) ✦ | 11.05M | +62.6% | $109.35M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 9 | Citadel Advisors ✦ | 10.47M | +40.9% | $103.62M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Arrowstreet Capital ✦ | 8.85M | +17.6% | $87.64M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 11 | Glenview Capital ✦ | 8.25M | 0.0% | $81.65M | 2.0% | Held | 6 | SEC ↗ |
| 12 | Millennium Management ✦ | 6.84M | -10.8% | $67.74M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 6.06M | +30.0% | $60.04M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 14 | Goldman Sachs Group ✦ | 5.48M | n/a | $54.26M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 15 | AQR Capital Management ✦ | 3.95M | +23.1% | $38.32M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 16 | Gotham Asset Management ✦ | 3.35M | +23.7% | $33.17M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 1.51M | +342.9% | $14.97M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 367.14K | -23.6% | $3.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 316.67K | -45.4% | $3.14M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 20 | GAMCO Investors ✦ | 287.99K | -2.1% | $2.85M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 39.89K | -95.8% | $394,951 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 11.73K | +12.4% | $116,155 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $103.09M | 曾为 0.0% |
| Capital World Investors | $988,355 | 曾为 0.0% |
| Two Sigma Investments | $230,251 | 曾为 0.0% |
| Soros Fund Management | $109,866 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,011 持有人, 984.50M 股份, $12.02B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Sep 08
SC 13G/A: FMR LLC
Aug 12
SC 13G/A: DAVIS SELECTED ADVISERS
Aug 06
SC 13G: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据